+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 13 Actively Recruiting clinical trials

P

Actively Recruiting

Heart failure is a leading cause of hospital admissions in Ghana, accounting for about 88.3 percent of cardiac admissions. Despite advances in heart failure treatments and guidelines, many patients experience hospital readmissions, which increase the risk of death. This study evaluates whether extensive post-discharge counseling combined with effective phone-based follow-up can reduce the rate of heart failure readmissions within 30 and 90 days at a major hospital in Ghana. It is a pilot randomized controlled trial involving patients admitted with heart failure. Participants are divided into two groups one receiving the usual care, which includes counseling by their attending physicians and regular outpatient reviews, and the other receiving additional support. The intervention group will receive extensive post-discharge counseling from a study doctor, pharmacist, or trained nurse, plus telephone follow-ups weekly for the first 30 days and then every four weeks until day 90. This additional support is given alongside their normal outpatient care. During the study, participants will be monitored for heart failure-related hospital readmissions at 30 and 90 days after discharge. Researchers will also assess readmission rates among those on guideline-directed heart failure medications, quality of life at 90 days, all-cause mortality within 30 and 90 days, and caregiver burden in managing heart failure at 30 days. The study is expected to continue through 2027, with close follow-up and data collection during and after the intervention period.

Age: 18Years +All GendersPhase Not Applicable
1 location
A

Actively Recruiting

Researchers are evaluating the ADHINCRA Program, a package of evidence-based interventions aimed at improving the control of hypertension among adults aged 18 to 70 in Africa. The program targets factors related to patients, healthcare providers, and health systems to help reduce risks of cardiovascular disease, stroke, and kidney disease. This interventional study is sponsored by Johns Hopkins University and focuses on managing high blood pressure using a nurse-led approach. The ADHINCRA Program includes home blood pressure monitoring, a mobile health application, nurse-led lifestyle counseling, and treatment using a simplified hypertension control protocol. Participants are divided into four cohorts starting the program at staggered intervals immediately, and 3, 6, and 9 months thereafter. All cohorts receive the same intervention to assess its effectiveness and implementation over time. Participants will be monitored for blood pressure control at baseline and at 12 and 24 months after starting the program. Assessments include systolic and diastolic blood pressure measurements, medication adherence via the Hill-Bone Medication Adherence Scale, and evaluation of how well the program is adopted and maintained at clinical sites. Researchers will also compare the cost of this intervention to usual care. The study is planned to end in September 2028, with ongoing safety and adherence monitoring throughout.

Age: 18Years - 70YearsAll GendersPhase Not Applicable
17 locations
O

Actively Recruiting

Healthy Volunteer

Researchers are conducting an anonymous online survey to assess the clinical knowledge of sepsis among healthcare professionals in seven sub-Saharan African countries. The study aims to identify knowledge gaps and training needs across different healthcare roles and compare knowledge scores over two survey waves. This research is part of a larger project supported by the German Federal Ministry of Research, Technology and Space and the STAIRS research network to improve sepsis care through education and capacity building. The survey will be performed in two separate cross-sectional waves a baseline survey from January 19, 2026, to April 30, 2026, and a follow-up survey from April 1, 2027, to July 31, 2027. Each wave will involve about 150 adult healthcare professionals or trainees from Uganda, Ethiopia, the Democratic Republic of the Congo, Mozambique, Ghana, Sierra Leone, and Nigeria. The project will also include webinars and a learning platform to support clinical capacity building in partner institutions. Participants will complete an anonymous online questionnaire assessing their general and domain-specific sepsis knowledge, self-assessed training needs, and professional role. The study will analyze and compare knowledge scores across countries and between the two survey waves. Data collection relies on internet access and language proficiency in English or French. The primary outcome is the sepsis knowledge score, with secondary outcomes including knowledge by professional role, country comparisons, and changes between survey waves.

Age: 18Years +All Genders
1 location
C

Actively Recruiting

Healthy Volunteer

This research aims to develop and refine quality indicators specifically adapted for early sepsis care in Sub-Saharan Africa. It uses a modified Delphi consensus method involving a series of three online surveys and structured feedback meetings. The study gathers expert opinions to create a context-sensitive approach to improving sepsis care in low- and middle-income countries. The study is observational and non-interventional, involving healthcare professionals experienced in sepsis care or research, including physicians, nurses, and researchers. Participants complete multiple rounds of surveys and provide feedback without any treatment or medication involved. The process is anonymous and conducted online, with recruitment aiming for 10 to 15 experts initially and up to 30 to 45 through nominations. Participants contribute by completing surveys and attending feedback meetings as part of the consensus-building process. Researchers measure the level of expert agreement on quality indicators and finalize a survey instrument structure and content for sepsis care evaluation. The study is conducted through to October 2026 and involves no direct medical procedures or interventions.

Age: 18Years +All Genders
1 location
G

Actively Recruiting

Healthy Volunteer

Researchers are investigating the genetic basis of Type 2 Diabetes T2D and related conditions among the Yoruba people in Ibadan, Nigeria, as part of a broader effort to understand how genetic and lifestyle factors contribute to T2D and its complications. This observational study aims to identify genetic variants linked to diabetes risk and to explore whether variants found in European populations also affect West Africans. The study also seeks to develop a large-scale genetic resource for future research and to describe cardiometabolic traits in diverse African populations. Participants include 300 unrelated cases of T2D and 300 matched controls without diabetes from the Yoruba ethnic group. Both newly diagnosed and treated T2D patients are enrolled. The study involves collecting blood and urine samples, measuring blood pressure and body composition, conducting eye exams, and administering questionnaires. Genetic analyses, including a genome-wide association study GWAS and resequencing of candidate genes, will be performed using samples processed in Nigeria and at the National Institutes of Health. During participation, individuals will undergo several assessments such as finger prick blood glucose tests, confirmatory fasting glucose tests when needed, and anthropometric measurements. Researchers will also perform eye examinations and gather detailed health information through questionnaires. The study will monitor a range of outcomes including T2D presence, hypertension, obesity, metabolic syndrome, and related kidney and lipid conditions. Participation involves initial testing and sample collection, with DNA analysis and genetic studies conducted subsequently, supporting ongoing research in diabetes genetics.

Age: 18Years - 120YearsAll Genders
5 locations
G

Actively Recruiting

This research aims to collect real-world data on patients with type 2 diabetes, hypertension, heart failure, and chronic kidney disease. It focuses on understanding patient characteristics, disease management, healthcare use, and outcomes across many countries. The study is an observational registry that includes patients seen in regular clinical practice worldwide. Participants are grouped based on their main condition or comorbidities, including type 2 diabetes, hypertension, chronic kidney disease, or heart failure. Data is collected both retrospectively and prospectively using a cloud-based electronic case report form accessible to investigators and a scientific committee. The registry is open to all physicians managing these conditions globally. Participants contribute information about their health status, treatments, and clinical measurements over time. Researchers gather demographic data, disease history, lab tests, imaging, medication use, healthcare visits, and outcomes such as hospitalizations and complications. The study measures many health indicators at baseline and averages over three years to understand care quality and disease progression. Participation can last until the study ends in 2030.

Age: 18Years +All Genders
76 locations
S

Actively Recruiting

The ICU-related Out-of-Pocket Expenses ICOPE study is a multinational, prospective observational study conducted in African and Asian countries to understand the financial impact of ICU care on patients and their families. The study focuses on measuring out-of-pocket expenses and the occurrence of catastrophic health expenditure among patients who stay in the ICU for more than 24 hours, including those who receive mechanical ventilation and those who do not. The study addresses the rising cost burden related to ICU care in low- and middle-income countries LMICs and aims to identify factors contributing to financial hardship. Participants include all patients admitted to participating ICUs during a 14-day recruitment period, with a planned sample size of at least 354 patients. The study compares groups of patients receiving invasive mechanical ventilation with those who do not, tracking their ICU-related expenses. The follow-up period extends from ICU admission to discharge, with additional assessments at 30 days and 6 months, spanning a total study duration of 18 months. During the study, researchers will collect detailed information about direct and indirect costs associated with ICU care, including medical and non-medical expenses. They will also examine how families cope with these costs and identify risk factors for catastrophic health expenditure. The primary outcomes include out-of-pocket cost per patient episode and the relative risk of catastrophic health expenditure by ICU discharge. Secondary outcomes include risk factors for catastrophic expenditure and the frequency of various coping strategies used by families.

All AgesAll Genders
44 locations
M

Actively Recruiting

Healthy Volunteer

Snakebite causes significant health problems and deaths worldwide, especially in low-income tropical countries like Ghana and Rwanda. This research aims to explore how spatial analysis and mapping techniques can help predict snakebite risks in different environments and evaluate the effectiveness of current data collection methods. The goal is to better understand geographical variations in snakebite risk and improve resource allocation for prevention and treatment. The study involves analyzing existing snakebite data from health facilities and conducting community surveys in selected areas of Ghana and Rwanda. These surveys will collect household-level data on snakebite experiences, combined with environmental and social factors, to create risk maps using geostatistical methods. The research will also compare these risk maps with current antivenom distribution to identify gaps and support better allocation of antivenoms. Participants will be part of household surveys and interviewed using structured questionnaires. Data collection will include mapping household locations with GPS and gathering detailed snakebite histories. Researchers will analyze the data to develop predictive models, validate findings, and assess the value of different data sources. The primary outcome is the number of people who have had a snakebite within one year. The study will continue until April 2027, with results shared with communities and published for wider scientific use.

All AgesAll Genders
1 location
R

Actively Recruiting

Researchers are conducting a randomized control trial to evaluate the Jada4 System, a novel vacuum-induced device designed to treat postpartum hemorrhage PPH, a leading cause of maternal death worldwide, especially in low and middle income countries. The study aims to compare the effectiveness, safety, and cost-effectiveness of this device against standard care in women experiencing PPH, defined as significant blood loss or symptoms of hypovolemia after childbirth. PPH commonly results from uterine atony, where the uterus does not contract properly after delivery. The trial includes two groups one group will receive the Jada4 System when initial medical treatments fail and blood loss reaches 1000 mL this device uses low-level vacuum pressure to help the uterus contract and control bleeding rapidly. The other group will receive standard care which may include additional medications, tranexamic acid, condom catheter balloon tamponade, or surgical interventions if bleeding continues. The device remains in place for at least one hour during treatment, followed by monitoring before removal. Participants are enrolled at two hospitals in Ghana, a country with a high burden of PPH. Participants will be monitored from delivery until six weeks postpartum. Researchers will assess maternal survival without needing surgery, time to control bleeding, hemoglobin levels, blood transfusion rates, surgical procedures, maternal death rates, additional medication use, patient satisfaction, and any adverse events related to the device. The study also evaluates quality of life and cost-effectiveness. Safety and treatment outcomes will be closely followed during this period to determine the devices potential benefits compared to standard care.

Age: 18Years - 44YearsFEMALEPhase Not Applicable
2 locations
E

Actively Recruiting

Researchers are evaluating the use of surfactant given by a less invasive surfactant administration LISA technique to treat respiratory distress syndrome in preterm infants in low- and middle-income African countries. This pragmatic clinical trial aims to determine whether this method improves survival compared to standard care, especially where invasive ventilators are not available. The study focuses on preterm neonates with respiratory distress who are managed with continuous positive airway pressure CPAP and caffeine citrate. The trial compares two groups one receiving standard care with CPAP and caffeine citrate, and the other receiving surfactant therapy administered through the LISA technique, which involves instilling surfactant into the lungs via a thin catheter during laryngoscopy while on CPAP. Participants are preterm infants born between 24 and 35 weeks gestation or weighing between 750 and 2000 grams with respiratory distress defined by a Silverman Anderson Score of 5 or greater. The study includes monitoring for complications and follows infants throughout hospitalization. Participants will be observed during their hospital stay, which averages about six months, to assess survival and other health outcomes such as incidence of major preterm neonatal morbidity and pneumothorax. Researchers will monitor participants from admission within 24 hours of life until discharge, evaluating hospital survival and complications related to respiratory distress and surfactant treatment. The primary outcome is all-cause in-hospital survival.

Age: 1Hour - 24HoursAll GendersPhase 4
8 locations

1-10 of 13

1